Physician profile
Jerome C Howell
NPI 1164400511
$410.93
in general payments reported to CMS, 2019-2025
10 companies · $104 in 2025
The $104 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.04 · 2022: $58.33 · 2023: $158 · 2024: $71.48 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.47 | 2023-2025 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $57.64 | 2022-2023 | Ultomiris |
| Janssen Pharmaceuticals, INC | $56.16 | 2020-2023 | Xarelto |
| Abbvie INC. | $54.18 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $35.20 | 2023 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $35.08 | 2022-2025 | Zerbaxa |
| Pfizer INC. | $21.63 | 2024 | |
| La Jolla Pharmaceutical Company | $18.74 | 2025 | Giapreza |
| Vertex Pharmaceuticals Incorporated | $16.30 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $13.53 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.